Dipeptidyl peptidase IV inhibitors as a potential target for diabetes: patent review (2015-2018)

.

Source: Expert Opinion on Therapeutic Patents - June 25, 2019 Category: Drugs & Pharmacology Authors: Hidayat Hussain Ghulam Abbas Ivan R. Green Iftikhar Ali Source Type: research